📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

High Value Chemicals From Plants Network

Lead Research Organisation: John Innes Centre
Department Name: UNLISTED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

The High Value Chemicals from Plants (HVCfP) Network aims to facilitate delivery of one of the four key objectives identified in the 2010 Department of Business Innovation and Skills report on 'Horizon Scanning and Road Mapping for Industrial Biotechnology through to 2025', which is to make the UK a leading producer of high value chemicals in plants. The scale of the economic opportunity associated with the extraction of high value chemicals from plants was summarised in the DBIS report. Plant-derived drugs represent 5.5% of the total pharmaceutical industry with sales revenue of £18 billion, oils and fats derived from oil-crops have a global market size of £500 million - £1 billion and functional foods and nutraceuticals have a global market of £45 billion. Other important applications and market sectors ranging from personal care to flavour and fragrance also rely increasingly on chemicals from plants as there is a growing demand for green, environmentally friendly and sustainable feedstocks across industrial sectors reducing our dependence on products derived from chemical
refineries. The objectives of the HVCfP Network are to:

Objective 1: Develop a cross-disciplinary community
Objective 2: Encourage interactions between research providers and users
Objective 3: Manage proof of concept funding
Objective 4: Develop challenges ready for future Industrial Biotechnology funding

Planned Impact

unavailable

Publications

10 25 50